KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Minority Interest (2016 - 2025)

Eli Lilly (LLY) has disclosed Minority Interest for 17 consecutive years, with $57.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Minority Interest fell 28.75% year-over-year to $57.5 million, compared with a TTM value of $57.5 million through Sep 2025, down 28.75%, and an annual FY2024 reading of $79.5 million, down 13.4% over the prior year.
  • Minority Interest was $57.5 million for Q3 2025 at Eli Lilly, down from $76.2 million in the prior quarter.
  • Across five years, Minority Interest topped out at $219.1 million in Q2 2021 and bottomed at $57.5 million in Q3 2025.
  • Average Minority Interest over 5 years is $113.8 million, with a median of $91.8 million recorded in 2023.
  • The sharpest move saw Minority Interest surged 69.43% in 2021, then crashed 51.4% in 2022.
  • Year by year, Minority Interest stood at $175.6 million in 2021, then decreased by 28.47% to $125.6 million in 2022, then dropped by 26.91% to $91.8 million in 2023, then fell by 13.4% to $79.5 million in 2024, then decreased by 27.67% to $57.5 million in 2025.
  • Business Quant data shows Minority Interest for LLY at $57.5 million in Q3 2025, $76.2 million in Q2 2025, and $82.0 million in Q1 2025.